News | September 23, 2022
Shilpa Medicare Hyderabad facility receives US FDA clearance
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
The Department of Health and Family Welfare updated the preparedness for transition to licensing of Class-A and Class-B medical devices with effect from 1st October, 2022 under Medical Devices Rules 2017
Results demonstrated a 64.5% confirmed objective response rate in patients treated with investigational combination of enfortumab vedotin and pembrolizumab
Phase 2 study to assess efficacy and safety of once daily linperlisib in patients with advanced peripheral T/NK cell lymphoma
The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers
To mark the occasion, Integrated Pharmaceutical Database Management System 2.0 (IPDMS 2.0), an integrated responsive cloud-based application developed by NPPA with technical support from C-DAC will be launched
The company shall be engaged in the business of manufacturing of pharmaceutical, bio-pharmaceutical and biological products of any kind
Subscribe To Our Newsletter & Stay Updated
